Main navigation

Products we regulate
Product safety
How we regulate
Guidance and resources

Teva Pharma Australia Pty Ltd

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

Cancellation by sponsor (156)
ARTG (126)
Prescription medicine registration (23)
Australian Public Assessment Report (AusPAR) (7)
Prescription medicine decision summary (3)
Section 14, TGO91 consent (2)
Designation or determination (1)

Date

2024 (120)
2023 (16)
2022 (13)
2021 (68)
2020 (23)
2019 (11)
2018 (6)
2017 (8)
2016 (25)
2015 (9)
2012 (2)
2011 (4)
2010 (1)
2006 (3)
2002 (7)
1995 (2)

Results for "[search-keyword]"

Search

Sponsor content

318 result(s) found, displaying 131 to 140

ABIRATERONE-TEVA (Teva Pharma Australia Pty Ltd)

16 August 2023

Prescription medicine registration

Active ingredients: Abiraterone acetate.
RASALECT rasagiline (as mesilate) 1 mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

30 June 2023

Cancellation by sponsor

Requested by Teva Pharma Australia Pty Ltd
RIVAROXABAN-TEVA rivaroxaban 15 mg tablet blister pack (369538)

17 May 2022

ARTG

Australian Register of Therapeutic Goods (ARTG) information for RIVAROXABAN-TEVA rivaroxaban 15 mg tablet blister pack.
RIVAROXABAN-TEVA rivaroxaban 20 mg tablet bottle (369545)

17 May 2022

ARTG

Australian Register of Therapeutic Goods (ARTG) information for RIVAROXABAN-TEVA rivaroxaban 20 mg tablet bottle.
RIVAROXABAN-TEVA rivaroxaban 2.5 mg tablet bottle (369548)

17 May 2022

ARTG

Australian Register of Therapeutic Goods (ARTG) information for RIVAROXABAN-TEVA rivaroxaban 2.5 mg tablet bottle.
RIVAROXABAN-TEVA rivaroxaban 15 mg tablet bottle (369535)

17 May 2022

ARTG

Australian Register of Therapeutic Goods (ARTG) information for RIVAROXABAN-TEVA rivaroxaban 15 mg tablet bottle.
RIVAROXABAN-TEVA rivaroxaban 20 mg tablet blister pack (369547)

17 May 2022

ARTG

Australian Register of Therapeutic Goods (ARTG) information for RIVAROXABAN-TEVA rivaroxaban 20 mg tablet blister pack.
RIVAROXABAN-TEVA rivaroxaban 10 mg tablet blister pack (369539)

17 May 2022

ARTG

Australian Register of Therapeutic Goods (ARTG) information for RIVAROXABAN-TEVA rivaroxaban 10 mg tablet blister pack.
RIVAROXABAN-TEVA rivaroxaban 10 mg tablet bottle (369549)

17 May 2022

ARTG

Australian Register of Therapeutic Goods (ARTG) information for RIVAROXABAN-TEVA rivaroxaban 10 mg tablet bottle.
RIVAROXABAN-TEVA rivaroxaban 2.5 mg tablet blister pack (369533)

17 May 2022

ARTG

Australian Register of Therapeutic Goods (ARTG) information for RIVAROXABAN-TEVA rivaroxaban 2.5 mg tablet blister pack.

Pages

First page
Previous page
…
Page 10
Page 11
Page 12
Page 13
Current page 14
Page 15
Page 16
Page 17
Page 18
…
Next page
Last page

Is there anything wrong with this page?

Help us improve the Therapeutic Goods Administration site

What were you doing? (mandatory)

What went wrong? (mandatory)

Leave this field blank

Using our website

Accessibility
Privacy
Disclaimer
Copyright
Freedom of information

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Subscribe to updates
Contact us
Facebook
(Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health and Aged Care acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.